12/23/2020 7:09:55 AM
Iterum Therapeutics' Michael Dunne Resigns As Chief Scientific Officer
12/7/2020 8:20:28 AM
Iterum Announces Filing Of A U.S. National Phase Patent Application
9/30/2020 7:11:27 AM
Iterum Therapeutics Announces Positive Pre-NDA Meeting With FDA For Sulopenem For Uncomplicated Urinary Tract Infections
9/2/2020 7:07:57 AM
Iterum Therapeutics Revises Results Of Its Pending Rights Offering